Ocular Therapeutix, Inc. (OCUL)
6.96
-0.33
(-4.53%)
USD |
NASDAQ |
Oct 02, 16:00
6.98
+0.02
(+0.29%)
After-Hours: 20:00
Ocular Therapeutix Price : 6.96 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 7.40 | 7.425 | 6.935 | 6.96 | 4.958M |
| Oct 01, 2026 | 7.63 | 7.705 | 7.26 | 7.29 | 4.514M |
| Sep 30, 2026 | 7.88 | 8.159 | 7.634 | 7.67 | 4.569M |
| Sep 29, 2026 | 7.80 | 8.13 | 7.510 | 7.87 | 5.287M |
| Sep 28, 2026 | 9.38 | 9.38 | 7.18 | 7.655 | 15.44M |
| Sep 25, 2026 | 9.77 | 9.85 | 9.585 | 9.65 | 1.622M |
| Sep 24, 2026 | 9.94 | 9.98 | 9.60 | 9.82 | 1.865M |
| Sep 23, 2026 | 10.48 | 10.57 | 9.77 | 10.00 | 2.089M |
| Sep 22, 2026 | 10.08 | 10.61 | 10.02 | 10.50 | 2.495M |
| Sep 21, 2026 | 10.08 | 10.17 | 9.81 | 9.99 | 2.073M |
| Sep 18, 2026 | 10.15 | 10.26 | 9.895 | 9.99 | 4.101M |
| Sep 17, 2026 | 10.11 | 10.54 | 10.06 | 10.14 | 2.311M |
| Sep 16, 2026 | 10.21 | 10.32 | 9.81 | 9.87 | 3.406M |
| Sep 15, 2026 | 10.80 | 10.89 | 10.13 | 10.19 | 2.099M |
| Sep 14, 2026 | 10.61 | 10.85 | 10.49 | 10.72 | 1.624M |
| Sep 11, 2026 | 10.75 | 10.94 | 10.36 | 10.49 | 2.639M |
| Sep 10, 2026 | 11.43 | 11.43 | 10.54 | 10.62 | 2.392M |
| Sep 09, 2026 | 11.24 | 11.48 | 11.02 | 11.47 | 2.805M |
| Sep 08, 2026 | 10.56 | 11.44 | 10.40 | 11.37 | 2.737M |
| Sep 04, 2026 | 10.51 | 10.77 | 10.51 | 10.64 | 1.307M |
| Sep 03, 2026 | 10.98 | 11.08 | 10.42 | 10.64 | 2.129M |
| Sep 02, 2026 | 10.58 | 11.01 | 10.47 | 10.90 | 2.069M |
| Sep 01, 2026 | 10.42 | 10.66 | 10.32 | 10.57 | 1.578M |
| Aug 31, 2026 | 10.30 | 10.54 | 10.13 | 10.49 | 1.521M |
| Aug 28, 2026 | 10.97 | 10.97 | 10.33 | 10.36 | 1.564M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| EyePoint, Inc. | 3.25 |
| ANI Pharmaceuticals, Inc. | 72.18 |
| Theravance Biopharma, Inc. | 17.03 |
| Corcept Therapeutics, Inc. | 116.23 |
| Veru, Inc. | 2.51 |
Price Related Metrics
| PS Ratio | 28.61 |
| PEG Ratio | -0.4648 |
| Price to Book Value | 2.939 |
| Earnings Yield | -20.30% |
| Market Cap | 1.528B |
| PEGY Ratio | -0.4648 |